CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Clinical trial NCT06149169 · UNKNOWN
Trial details
- NCT number
- NCT06149169
- Sponsor
- Shanghai Ming Ju Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2024-10-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.